Balyasny Asset Management »

Capricor Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Capricor Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Capricor Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capricor Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $10M 353k 28.86
2025-06-30 $2.4M 240k 9.93
2024-09-30 $228k 15k 15.21
2024-03-31 $88k 13k 6.79

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Tesla Motors Call Option (TSLA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr State Street Fin (XLF)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Vaneck Etf Trust Semiconductr Etf (SMH)
Broadcom Put Option (AVGO)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)

View all positions for Balyasny Asset Management

Top funds holding Capricor Therapeutics

BlackRock
Susquehanna International
Vanguard Group
Point72 Asset Management
Citadel Advisors
Suvretta Capital Management
Tang Capital Management
RA Capital Management
Geode Capital Management
FMR
J. Goldman & Co
Caption Management
State Street Corporation
Darwin Global Management
Millennium Management

View all funds holding Capricor Therapeutics